Invesco India Equity & Bond Fund - Regular Plan - Growth
Fund House: Invesco Mutual Fund| Category: Hybrid: Aggressive |
| Launch Date: 05-06-2018 |
| Asset Class: Mixed Asset |
| Benchmark: CRISIL Hybrid 35+65 Aggressive Index |
| TER: 2.41% As on (30-09-2023) |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 399.46 Cr As on (31-10-2023) |
| Turn over: 159% | Exit Load: For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
17.4315
0.03 (0.1509%)
10.71%
Benchmark: 12.43%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks to generate capital appreciation and current income by investing in equity & equity related instruments as well as debt securities.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 9.63 |
| Sharpe Ratio | 0.89 |
| Alpha | 1.06 |
| Beta | 0.73 |
| Yield to Maturity | 7.38 |
| Average Maturity | 6.0 |
PEER COMPARISON
Scheme Characteristics
Equity & Equity related instruments - between 65% and 80% of total assets; Debt instruments - between 20% and 35% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
10.24%
Others
27.81%
Large Cap
47.5%
Mid Cap
14.45%
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
